Drawing for CELLWAVE

USPTO serial 75394111

CELLWAVE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
FERRAIUOLO, DOMINIC
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELLWAVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer sofware for linking networks located in two or more different locations, using radios or wireless network cardsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 27, 1999ABN5ABANDONMENT - AFTER PUBLICATION—
Apr 19, 1999ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 23, 1999PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 19, 1999NPUBNOTICE OF PUBLICATION—
Jan 14, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 17, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 6, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance